Treatment with direct-acting antivirals improves peripheral insulin sensitivity in non-diabetic, lean chronic hepatitis C patients.

Giacomo GastaldiDiana GomesPhilippe SchneiterXavier MontetLuc TappySophie ClémentFrancesco Negro

Published in: PloS one (2019)

Pharmacological inhibition of HCV improves peripheral (but not hepatic) insulin sensitivity in non-diabetic, lean individuals with chronic hepatitis C without significant fibrosis.

Keyphrases

type diabetes
end stage renal disease
ejection fraction
newly diagnosed
liver fibrosis
hepatitis c virus
wound healing
patient reported outcomes
human immunodeficiency virus
replacement therapy
hiv infected
antiretroviral therapy